Chelsea Financial Services Supporting Boomer Esiason Foundation, CF Research at NYC Marathon

Chelsea Financial Services Supporting Boomer Esiason Foundation, CF Research at NYC Marathon

John Pirozzi, a representative of Chelsea Financial Services, will participate in the TCS New York City Marathon to raise money for cystic fibrosis research, the company announced.

Pirozzi is specifically running in support of the Boomer Esiason Foundation, a nonprofit group working to connect leaders in medicine and business to improve awareness and education about cystic fibrosis, as well as to fund research aimed at a cure and at improving the lives of people with this disease.

The foundation was founded in 1994 by Boomer and Cheryl Esiason after their son, Gunnar, was diagnosed with cystic fibrosis. Since its inception, it has raised more than $115 million to support research and people with CF.

A CrowdRise Fundraising Page, in support of the team Boomer effort at TCS NYC Marathon, has collected more $3,500 as of the writing of this article. The foundation is also promoting the use of the hashtag #FightCFwithBEF in support of those running in the Nov. 3 event, and the overall fundraising efforts.

Pirozzi has previously run in the Brooklyn Half Marathon; he also participated in a number of 5Ks — all with the goal of fundraising for worthy causes.

“Running is a big part of my daily routine. Even when I’m not running around my neighborhood in Prince’s Bay, running is incorporated into my training  … Plus, I’m running for a great cause, so that makes it all that more rewarding and motivating,” said Pirozzi in a press release.

The 26.2-mile marathon, which will take place in NYC on Sunday, Nov. 3, is being organized by the New York Road Runners. In 2018, there were over 50,000 race finishers, and more than $40 million was raised for charity.

The Boomer Esiason Foundation supports a number of educational scholarships for people with CF and their families members, and awarded nearly $100,000 in grants to patients needing lung transplants in 2018 to help with related expenses not covered by insurance. It also supports research and patient care at CF centers across the U.S.

Marisa, a science writer, holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.
Total Posts: 336
Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.
×
Marisa, a science writer, holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.
Average Rating
0 out of 5 stars. 0 votes.
My Rating: